Mannkind's Insulin Inhaler Receives FDA Approval

June 28, 2014 5:13 PM

4 0

The U.S. Food and Drug Administration has granted Mannkind Corp. clearance to sell Afrezza, a powder form of insulin created for controlling blood sugar levels in people with diabetes.

The U.S. Food and Drug Administration has granted Mannkind Corp. clearance to sell Afrezza, a powder form of insulin created for controlling blood sugar levels in people with diabetes.

Read more

To category page

Loading...